個々の患者のメタアナリシスにおける治療と用量の相互作用効果の後処理による調整のためのフレームワーク:プロジェクト・ハーモニーを用いた実証
Antonio A Morgan-López1, Shannon M Blakey1, Stephen G West2,3
1Center for Behavioral Health and Wellbeing, RTI International, Research Triangle Park, North Carolina.
Abstract:
Making causal statements regarding dose-response in treatments for posttraumatic stress disorder (PTSD) and alcohol/other drug use disorders (AODs; PTSD+AOD) is difficult because (a) dosage is rarely randomized and (b) self-selected dosage can be affected by treatment assignment. In the present study, we sought to clarify causal inferences regarding treatment-by-dosage interactions in PTSD+AOD treatment using Project Harmony, an individual-patient meta-analytic data set of behavioral, pharmacological, and combination PTSD+AOD treatments (k = 36; N = 4,046). Using propensity score weighting and moderated multilevel "net treatment difference" modeling, trauma-focused (TF) treatments, whether integrated or nonintegrated with AOD treatment, outperformed treatment as usual by greater margins on reductions in PTSD and alcohol use as dosage increased. Furthermore, appropriately treating dosage as a posttreatment covariate and moderator revealed effects for TF treatments on drug use that had not been detected in previous studies. Implications for approaches to increasing TF-treatment attendance and greater use of causal-inference methodologies with dose-response analyses are discussed.
さらに関連する動画
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
関連する概念動画
Dosage Regimens: Designs and Approaches
Dosage Regimens: Partial Pharmacokinetic Parameters
Dosage Regimen: Individualization
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
Dosage Regimen Designs: Nomograms and Tabulations
Therapeutic Drug Monitoring: Affecting Factors
